Telehealth Prescribing of Weight Loss Medications Faces Increased Scrutiny from Federal Agencies and State Boards
Rapid Read

Telehealth Prescribing of Weight Loss Medications Faces Increased Scrutiny from Federal Agencies and State Boards

What's Happening? Telehealth prescribing of GLP-1 class medications for weight loss is under intense examination by various regulatory bodies, including state medical boards, the Drug Enforcement Administration (DEA), the Food and Drug Administration (FDA), and the Federal Trade Commission (FTC). Th
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.